Qiu Yan, Zhang Yang, Li Yuhang, Ren Jie
Department of Basic Medical Sciences, Medical College, Xiamen University, Xiamen 361102, China.
Quality Responsibility Pharmaceuticals Co., Ltd., Wuhan Research & Development Center, Wuhan 430075, China.
Molecules. 2016 Feb 18;21(2):229. doi: 10.3390/molecules21020229.
Fatty Acid Amide Hydrolase (FAAH) is an intracellular serine enzyme involved in the biological degradation of the fatty acid ethanolamide family of signaling lipids, which exerts neuroprotective, anti-inflammatory, and analgesic properties. In the present study, a conjugated 2,4-dioxo-pyrimidine-1-carboxamide scaffold was confirmed as a novel template for FAAH inhibitors, based on which, a series of analogues had been prepared for an initial structure-activity relationship (SAR) study. Most of the synthesized compounds displayed moderate to significant FAAH inhibitory potency. Among them, compounds 11 and 14 showed better activity than others, with IC50 values of 21 and 53 nM. SAR analysis indicated that 2,4-dioxopyrimidine-1-carboxamides represented a novel class of potent inhibitors of FAAH, and substitution at the uracil ring or replacement of the N-terminal group might favor the inhibitory potency. Selected compounds of this class may be used as useful parent molecules for further investigation.
脂肪酸酰胺水解酶(FAAH)是一种细胞内丝氨酸酶,参与信号脂质脂肪酸乙醇酰胺家族的生物降解,具有神经保护、抗炎和镇痛特性。在本研究中,一种共轭的2,4-二氧代嘧啶-1-甲酰胺支架被确认为FAAH抑制剂的新型模板,基于此,已制备了一系列类似物用于初步的构效关系(SAR)研究。大多数合成化合物表现出中度至显著的FAAH抑制活性。其中,化合物11和14表现出比其他化合物更好的活性,IC50值分别为21和53 nM。SAR分析表明,2,4-二氧代嘧啶-1-甲酰胺代表了一类新型的强效FAAH抑制剂,尿嘧啶环上的取代或N端基团的替换可能有利于提高抑制活性。这类选定的化合物可作为有用的母体分子用于进一步研究。